HSIC
Price
$69.09
Change
+$0.60 (+0.88%)
Updated
Apr 1, 04:59 PM (EDT)
Capitalization
9.7B
41 days until earnings call
MCK
Price
$673.97
Change
+$0.98 (+0.15%)
Updated
Apr 1, 04:59 PM (EDT)
Capitalization
70.55B
41 days until earnings call
Ad is loading...

HSIC vs MCK

Header iconHSIC vs MCK Comparison
Open Charts HSIC vs MCKBanner chart's image
Henry Schein
Price$69.09
Change+$0.60 (+0.88%)
Volume$17.39K
Capitalization9.7B
McKesson
Price$673.97
Change+$0.98 (+0.15%)
Volume$1.34K
Capitalization70.55B
HSIC vs MCK Comparison Chart
Loading...
HSIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MCK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HSIC vs. MCK commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HSIC is a StrongBuy and MCK is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (HSIC: $68.49 vs. MCK: $672.99)
Brand notoriety: HSIC: Not notable vs. MCK: Notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: HSIC: 58% vs. MCK: 118%
Market capitalization -- HSIC: $9.7B vs. MCK: $70.55B
HSIC [@Medical Distributors] is valued at $9.7B. MCK’s [@Medical Distributors] market capitalization is $70.55B. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $9.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HSIC’s FA Score shows that 0 FA rating(s) are green whileMCK’s FA Score has 4 green FA rating(s).

  • HSIC’s FA Score: 0 green, 5 red.
  • MCK’s FA Score: 4 green, 1 red.
According to our system of comparison, MCK is a better buy in the long-term than HSIC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HSIC’s TA Score shows that 4 TA indicator(s) are bullish while MCK’s TA Score has 3 bullish TA indicator(s).

  • HSIC’s TA Score: 4 bullish, 5 bearish.
  • MCK’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, MCK is a better buy in the short-term than HSIC.

Price Growth

HSIC (@Medical Distributors) experienced а -3.21% price change this week, while MCK (@Medical Distributors) price change was +1.84% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was -0.92%. For the same industry, the average monthly price growth was -5.88%, and the average quarterly price growth was -6.69%.

Reported Earning Dates

HSIC is expected to report earnings on May 13, 2025.

MCK is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Medical Distributors (-0.92% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MCK($70.5B) has a higher market cap than HSIC($9.71B). MCK (24.25) and HSIC (23.50) have similar P/E ratio . MCK YTD gains are higher at: 18.218 vs. HSIC (-1.026). MCK has higher annual earnings (EBITDA): 4.44B vs. HSIC (877M). MCK has more cash in the bank: 1.98B vs. HSIC (171M). HSIC has less debt than MCK: HSIC (2.74B) vs MCK (7.61B). MCK has higher revenues than HSIC: MCK (302B) vs HSIC (12.3B).
HSICMCKHSIC / MCK
Capitalization9.71B70.5B14%
EBITDA877M4.44B20%
Gain YTD-1.02618.218-6%
P/E Ratio23.5024.2597%
Revenue12.3B302B4%
Total Cash171M1.98B9%
Total Debt2.74B7.61B36%
FUNDAMENTALS RATINGS
HSIC vs MCK: Fundamental Ratings
HSIC
MCK
OUTLOOK RATING
1..100
8124
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
22
Undervalued
PROFIT vs RISK RATING
1..100
694
SMR RATING
1..100
6499
PRICE GROWTH RATING
1..100
596
P/E GROWTH RATING
1..100
5121
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MCK's Valuation (22) in the Medical Distributors industry is somewhat better than the same rating for HSIC (82). This means that MCK’s stock grew somewhat faster than HSIC’s over the last 12 months.

MCK's Profit vs Risk Rating (4) in the Medical Distributors industry is somewhat better than the same rating for HSIC (69). This means that MCK’s stock grew somewhat faster than HSIC’s over the last 12 months.

HSIC's SMR Rating (64) in the Medical Distributors industry is somewhat better than the same rating for MCK (99). This means that HSIC’s stock grew somewhat faster than MCK’s over the last 12 months.

MCK's Price Growth Rating (6) in the Medical Distributors industry is somewhat better than the same rating for HSIC (59). This means that MCK’s stock grew somewhat faster than HSIC’s over the last 12 months.

MCK's P/E Growth Rating (21) in the Medical Distributors industry is in the same range as HSIC (51). This means that MCK’s stock grew similarly to HSIC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HSICMCK
RSI
ODDS (%)
Bullish Trend 2 days ago
57%
Bearish Trend 2 days ago
49%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
54%
Bearish Trend 2 days ago
46%
Momentum
ODDS (%)
Bearish Trend 2 days ago
65%
Bullish Trend 7 days ago
69%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
48%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
56%
Bullish Trend 2 days ago
62%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
53%
Bullish Trend 2 days ago
63%
Advances
ODDS (%)
Bullish Trend 15 days ago
56%
Bullish Trend 2 days ago
66%
Declines
ODDS (%)
Bearish Trend 2 days ago
54%
Bearish Trend 9 days ago
42%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
69%
Bearish Trend 2 days ago
44%
Aroon
ODDS (%)
Bearish Trend 2 days ago
47%
Bullish Trend 2 days ago
67%
View a ticker or compare two or three
Ad is loading...
HSIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MCK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SDY135.681.39
+1.04%
SPDR® S&P Dividend ETF
FQAL64.160.57
+0.89%
Fidelity Quality Factor ETF
PHDG36.480.32
+0.88%
Invesco S&P 500® Downside Hedged ETF
TMFX18.280.02
+0.08%
Motley Fool Next ETF
KJAN35.74-0.15
-0.42%
Innovator US Small Cap Pwr Buff ETF™ Jan

HSIC and

Correlation & Price change

A.I.dvisor indicates that over the last year, HSIC has been loosely correlated with PDCO. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if HSIC jumps, then PDCO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HSIC
1D Price
Change %
HSIC100%
-0.19%
PDCO - HSIC
40%
Loosely correlated
+0.10%
CAH - HSIC
20%
Poorly correlated
+0.97%
OMI - HSIC
19%
Poorly correlated
+5.24%
COR - HSIC
18%
Poorly correlated
+1.05%
ZYXI - HSIC
16%
Poorly correlated
-2.22%
More

MCK and

Correlation & Price change

A.I.dvisor indicates that over the last year, MCK has been loosely correlated with COR. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if MCK jumps, then COR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MCK
1D Price
Change %
MCK100%
+0.74%
COR - MCK
60%
Loosely correlated
+1.05%
CAH - MCK
45%
Loosely correlated
+0.97%
OMI - MCK
9%
Poorly correlated
+5.24%
SHTDF - MCK
9%
Poorly correlated
N/A
HSIC - MCK
5%
Poorly correlated
-0.19%
More